Systemic Markers of Inflammation in Smokers With Symptoms Despite Preserved Spirometry in SPIROMICS

Document Details

Document Type
Pub Defense Publication
Publication Date
May 01, 2019
Source ID
10.1016/j.chest.2018.12.022

Entities

People

  • Alejandro Comellas
  • Annette T. Hastie
  • Christopher B. Cooper
  • David J. Couper
  • Eugene R. Bleecker
  • Fernando J. Martinez
  • Gerard Criner
  • Jeffrey L. Curtis
  • Jerry A. Krishnan
  • Mark T Dransfield
  • Meilan K. Han
  • Nadia N. Hansel
  • Neil E. Alexis
  • Prescott G. Woodruff
  • R. Graham Barr
  • Robert Paine Iii
  • Russell P. Bowler
  • Stephanie A. Christenson
  • Stephen P. Peters
  • Suresh Garudadri
  • Wanda K. O’neal

Organizations

  • Actelion
  • American College of Chest Physicians
  • AstraZeneca
  • AstraZeneca (United States)
  • Boehringer Ingelheim
  • COPD Foundation
  • Chiesi Farmaceutici S.p.A.
  • Forest Laboratories
  • GSK
  • Hoffmann-La Roche
  • Ikarian
  • National Heart, Lung, and Blood Institute
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Environmental Health Sciences
  • National Institutes of Health
  • Novartis
  • Regeneron Pharmaceuticals
  • Roche (United States)
  • Sanofi-Aventis
  • Sunovion
  • United States Department of Defense
  • United States Department of Veterans Affairs